Biotechnology Stocks
| # | Ultimi 7 Giorni | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 4404 |  MCRB Seres Therapeutics, Inc. - Common Stock | 2.63 USD | -3.31% | -11.74% | -49.52% | -68.04% | 26.15 M USD | ||
| 4406 |  ABVC ABVC BioPharma, Inc. - Common Stock | 0.98 USD | -2.00% | -4.85% | +6.52% | -69.94% | 26.12 M USD | ||
| 4408 |  ATYR aTyr Pharma, Inc. - Common Stock | 0.26 USD | -7.14% | -10.34% | -44.68% | -73.20% | 25.50 M USD | ||
| 4410 |  EVAX Evaxion A/S - American Depositary Share | 3.05 USD | -2.87% | -5.57% | -7.29% | -8.13% | 25.44 M USD | ||
| 4415 |  BYSI BeyondSpring, Inc. - Ordinary Shares | 0.61 USD | -4.69% | -26.51% | 0.00% | -66.67% | 25.08 M USD | ||
| 4432 |  ATOS Atossa Therapeutics, Inc. - Common Stock | 2.42 USD | -1.63% | +8.52% | +2.54% | +106.84% | 24.15 M USD | ||
| 4433 |  KYNB Kyntra Bio, Inc. - Common Stock | 5.96 USD | -1.32% | -9.70% | -29.22% | -37.33% | 24.13 M USD | ||
| 4474 |  COCP Cocrystal Pharma, Inc. - Common Stock | 1.07 USD | 0.00% | -8.55% | -15.08% | -13.71% | 20.61 M USD | ||
| 4503 |  JSPR Jasper Therapeutics, Inc. - Class A Common Stock | 0.56 USD | -1.75% | -6.67% | -18.84% | -77.60% | 18.63 M USD | ||
| 4504 |  ESLA Estrella Immunopharma, Inc. - Common Stock | 0.42 USD | 0.00% | -8.70% | -32.26% | -66.40% | 18.27 M USD | ||
| 4509 |  NEUP Neuphoria Therapeutics Inc. - Common Stock | 3.35 USD | -2.05% | -6.69% | -11.61% | -82.41% | 18.13 M USD | ||
| 4528 |  GNTA Genenta Science S.p.A. - American Depositary Shares | 0.71 USD | -6.58% | -13.41% | -23.66% | -78.81% | 16.64 M USD | ||
| 4532 |  AKTX Akari Therapeutics Plc - American Depositary Shares | 8.49 USD | -1.62% | -5.77% | -20.13% | +793.68% | 16.53 M USD | ||
| 4538 |  ACTU Actuate Therapeutics, Inc. - Common stock | 0.68 USD | -5.56% | -26.88% | -45.60% | -83.33% | 16.33 M USD | ||
| 4541 |  BCDA BioCardia, Inc. - Common Stock | 1.06 USD | -2.75% | +1.92% | -2.75% | -8.62% | 16.05 M USD | ||
| 4543 |  PTN Palatin Technologies, Inc. Common Stock | 9.01 USD | -5.36% | +3.56% | -26.57% | +24.28% | 16.05 M USD | ||
| 4544 |  DYAI Dyadic International, Inc. - Common Stock | 0.44 USD | -4.35% | -4.35% | -13.73% | -61.06% | 16.03 M USD | ||
| 4546 |  LPCN Lipocine Inc. - Common Stock | 1.93 USD | -12.27% | -8.53% | -17.87% | -33.45% | 15.91 M USD | ||
| 4548 |  MRKR Marker Therapeutics, Inc. - Common Stock | 0.95 USD | -8.65% | -10.38% | -21.49% | -10.38% | 15.84 M USD | ||
| 4554 |  ALLR Allarity Therapeutics, Inc. - Common stock | 0.98 USD | 0.00% | -7.55% | -24.03% | -44.32% | 15.59 M USD |
Notizie Biotechnology Stocks
Il farmaco di Pharvaris per l’HAE mostra un sollievo più rapido
Raymond James avvia la copertura di Kymera Therapeutics con rating outperform
Raymond James avvia la copertura di Nektar con rating Market Perform
Palisade Bio: Raymond James avvia copertura con rating Outperform
Raymond James conferma il rating su Liquidia tra i ricorsi legali
Tenax Therapeutics sospende temporaneamente l’arruolamento nello studio LEVEL-2 di TNX-103 per modificare i criteri; richiede un incontro con la FDA
Ginkgo Bioworks supporterà NSF X-Labs con accesso al laboratorio
Gainers Biotechnology Stocks
 GRDX GridAI Technologies Corp. - Common Stock | 4.80 | +16.50% |
 CLGN CollPlant Biotechnologies Ltd. - Ordinary Shares | 3.97 | +14.74% |
 IPSC Century Therapeutics, Inc. - Common Stock | 1.46 | +14.06% |
 ADCT ADC Therapeutics SA Common Shares | 1.59 | +11.97% |
 CDTTW CDT Equity Inc. - Warrant | 0.0117 | +11.43% |
 SRZN Surrozen, Inc. - Common Stock | 27.97 | +11.26% |
 ANL Adlai Nortye Ltd - American Depositary Shares | 15.51 | +10.39% |
 QNCX Quince Therapeutics, Inc. - Common Stock | 29.36 | +9.88% |
Losers Biotechnology Stocks
 SABSW SAB Biotherapeutics, Inc. - Warrant | 0.0088 | -27.87% |
 YDESW YD Bio Limited - Warrants | 0.5000 | -23.08% |
 CRBU Caribou Biosciences, Inc. - Common Stock | 0.48 | -22.58% |
 TCRX TScan Therapeutics, Inc. - Common Stock | 0.23 | -17.86% |
 KALA KALA BIO, Inc. - Common Stock | 0.30 | -16.67% |
 BRTX BioRestorative Therapies, Inc. - Common Stock | 1.89 | -15.62% |
 MLEC Moolec Science SA - Ordinary Shares | 4.19 | -12.89% |
LPCN Lipocine Inc. - Common Stock | 1.93 | -12.27% |